With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

The approach could help test hypotheses about how atypical function of the brain’s immune cells contributes to autism.

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.

Once thought only to attack neurons, immune cells turn out to be vital for central nervous system function.

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

Can mice with humanlike tissues better model drug effects in people?

Odor, taste, and light receptors are present in many different parts of the body, and they have surprisingly diverse functions.

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Researchers and pharma companies have tried to attack this disease by reducing amyloid plaques, but inflammation may be the real culprit.